Emcure Pharmaceuticals IPO

[{"selector":"#anim-24910f05-5a4e-4ec6-bb3e-0846821ca7e5","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-36461b70-0dc1-41d7-8fc4-d7f9c11ad9f9","keyframes":{"transform":["translate3d(-114.24333%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-fdab0583-dd19-45ab-b273-4fb4e212fa02","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-f855e5e4-eb08-46c3-9e9b-7504adaf9e49","keyframes":{"transform":["translate3d(115.18987%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-dd4ff936-6f6a-4664-b8bf-412443f67cfb [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-34.249999904429615%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}] Emcure Pharmaceuticals plans an IPO of INR 1,952.03 crores, with INR 800 crores as fresh issue and offers to sell 1.152.03 crores equity shares for debt repayment and corporate uses. Read more

Important Details

[{"selector":"#anim-d1651958-3013-4405-995c-83c1756655b3 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-31.18437488582752%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}] [{"selector":"#anim-6d155098-410a-42b8-b5c2-2fbd8e560a13","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-90eadc7a-9fdf-48b5-917c-5231323d0d7a","keyframes":{"transform":["translate3d(-114.24333%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-18ccf9b9-94ee-462d-b940-32dec023095f","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-d5b14390-85eb-4473-8f04-c1f8e6310935","keyframes":{"transform":["translate3d(115.18987%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Open Date : July 3, 2024 Close Date : July 5, 2024 Allotment Date: July 8, 2024 Listing Date: July 10, 2024 Important Details

Important Details

[{"selector":"#anim-7d310629-075c-4655-ae06-01e293eb2791 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-27.555747633463046%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}] [{"selector":"#anim-1c17565d-d502-4f0e-8557-76e9d3a5eb4d","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-539370e7-1c37-4deb-b961-2ecfec71f3f5","keyframes":{"transform":["translate3d(-114.24333%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-d7dfdf30-28b3-4eed-a131-aa6c48b9f0ac","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-e57d8e29-38eb-49f3-8344-0f20063cd9ff","keyframes":{"transform":["translate3d(115.18987%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] IPO Price: INR 960-1008 per share Lot Size: 14 Shares Total Issue Size: INR 1,952.03 crores Important Details

Fundamental Analysis

[{"selector":"#anim-0ce9c314-4bca-4080-876d-2661ed1dae81 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-37.63464008545229%, 0, 0) translate(-16.778523489932883%, 9.401231690613525%) scale(1.3355704697986577)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}] [{"selector":"#anim-424433d7-0b27-4adf-a942-df170d295cfb","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-e20c56ce-0aa2-4748-aee3-ce8c8486ed0f","keyframes":{"transform":["translate3d(-114.24333%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-501dc673-fa63-4841-a229-6e6c906354a7","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-32535854-4d9b-4517-b66b-a1046d024598","keyframes":{"transform":["translate3d(115.18987%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Emcure Pharmaceuticals IPO analysis shows mixed performance: 1. Steady revenue growth,Declining profitability. 2. Lower EPS and RoNW. 3. Improved liquidity,Increased total assets. Fundamental Analysis

Peer Comparison

[{"selector":"#anim-75841fb5-7c50-4b33-ac8a-1c23785bf4b8 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-13.184374784763953%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}] [{"selector":"#anim-fd14cd63-46e5-42c9-abf3-4abc369b1709","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-19c55e71-5e66-4872-94b9-7cb8681cefd5","keyframes":{"transform":["translate3d(-114.24333%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-726740f7-ce25-4b24-bcbb-564eb0e7f5df","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-8c41539b-55c6-4cdc-90c9-050632f819d7","keyframes":{"transform":["translate3d(115.18987%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Emcure Pharmaceuticals : Revenue ₹59,858.11 million,Competitive financials among peers. Abbott India : High EPS and RoNW. Dr. Reddy’s Laboratories: Strong P/E and NAV. Peer Comparison

Objective

[{"selector":"#anim-0e7be55a-e087-461a-8ded-cd10288acd2b [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-38.92779011077786%, 0, 0) translate(-12.5%, -7.910156417989537%) scale(1.25)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}] [{"selector":"#anim-1fce0719-06de-4fea-9f3e-f9102006c1b0","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-8e1920aa-3784-499e-95bc-329d7fea3325","keyframes":{"transform":["translate3d(-114.24333%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-968c11bb-3d0b-4a93-a5c7-4f6e0a3abf13","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-b671340f-a565-40d5-a3aa-b0b7b8174a67","keyframes":{"transform":["translate3d(115.18987%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Emcure Pharmaceuticals Limited’s IPO aims to repay and prepay certain outstanding borrowings. Objective

Risks And Challenges

[{"selector":"#anim-054d95ec-6e28-4b3e-a9c7-c0db310cd580 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-36.774672222142215%, 0, 0) translate(-17.730496453900713%, 17.714133677937554%) scale(1.3546099290780143)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}] [{"selector":"#anim-c0f83e07-2145-4877-8bc0-d2fa2870f890","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-1934819a-f9cb-4f4d-8e94-c898864220ed","keyframes":{"transform":["translate3d(-114.24333%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-8aa3b29b-bf1d-4528-b76b-7879507c94fd","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-958ba98a-a588-4e80-be38-f60b65c41c6d","keyframes":{"transform":["translate3d(115.50632%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Emcure Pharmaceuticals IPO risks : 1. Regulatory compliance. 2. Potential product recalls. 3. Supply chain disruptions. 4. Dependency on local distributors. 5. Delays in approvals affecting operations and finances. Risks And Challenges

Check Out More IPO Review Articles

[{"selector":"#anim-b1d58106-fe80-4185-a875-a1a07e84a212","keyframes":{"opacity":[0,1]},"delay":300,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-04534703-143e-4d0f-8556-4394cdeecb04","keyframes":{"transform":["translate3d(84.21055%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":300,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-34d74974-f22d-4b93-b4c9-046fa3a4d4bc","keyframes":{"opacity":[0,1]},"delay":300,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-0719b323-9416-4b26-967f-83478c421117","keyframes":{"transform":["translate3d(56.00001%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":300,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-aaf84aaa-3f2e-4718-8530-bafc3cfe2d0b","keyframes":{"transform":["translate3d(-135.29412%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1000,"easing":"cubic-bezier(.2, 0, .8, 1)","fill":"both"}] [{"selector":"#anim-7cf8449b-d63c-4111-ba8c-c04abb9c85f5","keyframes":{"transform":["rotateZ(-180deg)","rotateZ(0deg)"]},"delay":0,"duration":1000,"easing":"cubic-bezier(.2, 0, .5, 1)","fill":"forwards"}] [{"selector":"#anim-379b16a9-5ad0-46ef-bfa0-e546c343286a","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-b7bb3905-7d94-4162-95fe-af54946b4558","keyframes":{"transform":["translate3d(-119.59459%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-2dcf6a75-7030-4ee4-a97d-6856e94d7bdc","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-97b9501a-6e7a-4430-b175-e2befd6742da","keyframes":{"transform":["translate3d(-119.59459%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-17d331a2-6450-4d05-bc52-e07d7bc43352 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-40.941741011719394%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}] Disclaimer *T&C Apply Open Account Now!